How should heart failure patients be monitored after discharge to reduce readmission?

• A. Early follow-up within 1-2 weeks with weight monitoring and medication reconciliation
• B. Visit only if symptoms worsen, no mandated follow-up
• C. Daily imaging studies to monitor heart size
• D. No follow-up necessary if asymptomatic

Answer: (A)

The main idea is catching decompensation early after discharge with a structured follow-up that includes objective data and therapy optimization. An early follow-up visit within 1–2 weeks lets the clinician verify the patient’s status, review weight trends, adjust diuretics and other heart-failure medications as needed, and reconcile all medications to prevent omissions, duplications, or adverse interactions. Weight monitoring is a simple, powerful signal of fluid retention—small increases can precede worsening symptoms, so having the patient track weight and discuss changes at the follow-up helps prevent readmission. Medication reconciliation ensures the patient is on the correct regimen and adherent, which directly impacts outcomes.

Waiting for symptoms to worsen misses early warning signs, since patients may underreport or not notice subtle changes. Daily imaging to monitor heart size isn’t practical or necessary for routine post-discharge care, and no follow-up when asymptomatic ignores ongoing risk after discharge.